VIR
Vir BiotechnologyCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The Q1 update materially strengthened the balance-sheet and execution narrative: the Astellas collaboration closed, management pointed to $315 million of collaboration-related cash not yet in the March 31 balance, runway was extended into the second half of 2028, and the company kept multiple 2026 data hooks across CHD and oncology [#8-K-2026-05-06] [#10-Q-2026-05-07].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +1.9.
What can break
Lead-program risk remains high because the biggest value inflection is still late-2026 ECLIPSE 1 topline in chronic hepatitis delta, with later ECLIPSE 2 and 3 data following in 2027 [#10-Q-2026-05-07].
Momentum
63
Value
41
Sentiment
58
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.50 · Bull $16.00 · Bear $6.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $21.56
Why
Momentum63 · Δ7d -14.4
Value41 · Δ7d +0.0
Sentiment58 · Δ7d +1.9
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
63
26% active weight
Current posture
7d trendFlat
Δ7d
-14.4
Δ21d
+2.5
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
58
34% active weight
Current posture
7d trendImproving
Δ7d
+1.9
Δ21d
+4.7
Why this grade
Composite grade C. Momentum 63.5 / Value 41.1 / Sentiment 58.1
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.56B
Beta
1.69
Shares Out
168.65M
P/E (TTM) · Derived
-2.9
P/S (TTM)
47.78
P/FCF (TTM) · Derived
-2.90
Rev YoY
-101.0%
EPS YoY
-3.1%
Gross Margin
+82.2%
Op Margin
-3253.6%
Net Debt
-$371.09M
Current Ratio
7.11
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology